Specifications
Species Reactivity
Mouse, Rat
Immunogen
Mouse myeloma cell line NS0-derived recombinant rat Neuropilin‑1; Phe22-Ala810 (Lys811Arg), Ser829-Asp854
Conjugate
Functional Grade
Applications
Application Notes
Recommended concentration:
WB: 0.1 μg/ml
FC: 2.5 μg/10^6 cells
IHC: 3-15 μg/mL
Target
Alternative Names
BDCA4; BDCA-4; CD304 antigen; CD304; DKFZp686A03134; DKFZp781F1414; neuropilin 1; Neuropilin1; Neuropilin-1; NP1; NRP; NRP1; transmembrane receptor; Vascular endothelial cell growth factor 165 receptor; VEGF165R
Citations
Have you cited CABT-Z388G in a publication?
Let us know and earn a reward for your research.
Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Yacoub, M; Coulon, A; et al. Differential expression of the semaphorin 3A pathway in prostatic cancer. HISTOPATHOLOGY 55:392-398(2009).
Patnaik, A; LoRusso, PM; et al. A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors. CANCER CHEMOTHERAPY AND PHARMACOLOGY 73:951-960(2014).